Rebif 44 MCG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FC56G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,917
Award facts
- Contract value 100% obligated
- $12,916.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for REBIF 44 MCG/0.5 ML syringes, valued at $12,916.95 with a firm fixed price. The contract, awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. REBIF (interferon beta-1a) is a neurological therapeutic used to treat multiple sclerosis, demonstrating the company's ongoing role in supplying specialized pharmaceutical products to support military healthcare requirements.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant IDC with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, serving as a comprehensive global pharmaceutical support vehicle. This prime contract enables the company to supply a broad range of medications, vaccines, syringes, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The current delivery order exemplifies the company's consistent capability to fulfill federal medical supply needs through open competition and firm fixed pricing arrangements.
Quick answers
Who was awarded contract SPE2DB25FC56G?
SPE2DB25FC56G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 25, 2025.
How much is contract SPE2DB25FC56G worth?
The government has obligated $12,917 on SPE2DB25FC56G.
Is contract SPE2DB25FC56G an order under another contract?
Yes. SPE2DB25FC56G is a delivery order under SPE2DB20D2014, an indefinite delivery contract.
Was contract SPE2DB25FC56G competed?
The extent of competition for SPE2DB25FC56G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award